Abstract:Objective To explore the suitable ways screening of type 2 diabetes mellitus (T2DM) and DM related high-risk population. Methods The 16 056 subjects from Shougang community were studied. The oral glucose tolerance test (OGTT) was performed and the HbA1c, FPG and 2 h PG were examined in all subjects in the screening. Receiver operating characteristic (ROC) curve analysis was used to examine the sensitivity and specificity of FPG, HbA1c and 2 h PG for diagnosing T2DM and DM related high-risk population, which was defined by the standard from WHO in 1999. Results According to the OGTT standard of screening for DM, which was FPG≥7.0 mmol/L or 2 h PG≥11.1 mmol/L, the detection rates were 12.52% for T2DM and 26.99% for DM related high-risk population. With HbA1c≥6.5% for the screen of DM, the rate of missed diagnosis was 46.59%. With FPG≥7.0 mmol/L, the rate of missed diagnosis was 50.02%. Based on the ROC curve, the optimal cut-points of FPG related to the OGTT-diagnostic criteria for DM was 6.1 mmol/L which was associated with a sensitivity and specificity of 75.5% and 90.3% respectively. The optimal cut-points of HbA1c related to T2DM diagnosis by OGTT was 6.2%, which was associated with a sensitivity and specificity of 71.4% and 84.5% respectively. The optimal cut-points of 2 h PG related to T2DM diagnosis by OGTT was 11.1%, which was associated with a sensitivity and specificity of 87.7% and 100% respectively. The optimal cut-points of FPG related to the OGTT-diagnostic criteria for T2DM and DM related high-risk population was 5.7 mmol/L which was associated with a sensitivity and specificity of 62% and 87.2% respectively. The optimal cut-points of HbA1c related to T2DM and DM related high-risk population diagnosis by OGTT was 6.0%, which was associated with a sensitivity and specificity of 57.3% and 77.4% respectively. The optimal cut-points of 2 h PG related to T2DM and DM related high-risk population diagnosis by OGTT was 7.8%, which was associated with a sensitivity and specificity of 86.7% and 100% respectively. The screening model using FPG≥6.1 mmol/L or HbA1c≥6.2% had sensitivities 85.3% for detecting T2DM and using FPG≥5.6 mmol/L or HbA1c≥6.1% had sensitivities 74.4% for detecting T2DM and DM related high-risk population. Conclusions The simultaneous measurement of FPG and HbA1c might be a more sensitive and specific screening tool for identifying high-risk individuals for T2DM at an early stage.

Comparison of effect of different ways on screening type 2 diabetes Mellitus and DM related high-risk population

Evaluation of Effects of Five Screening Methods for Asymptomatic Type 2 Diabetes

Combined Use of Fasting Plasma Glucose and Glycated Hemoglobin A1c in the Screening of Diabetes and Impaired Glucose Tolerance

Fasting plasma glucose and HbA1c as a screening test for diabetes mellitus

The Clinical Significance of HbA1c Combined with Fasting Blood Glucose for Screening Glucose Metabolism Abnormality in High Risk Subjects of Type 2 Diabetes

Performance and Costs of Multiple Screening Strategies for Type 2 Diabetes: Two Population-Based Studies in Shanghai, China

Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population

Efficiency of fingertip blood glucose combined with Chinese Diabetes Risk Score in screening diabetes mellitus and pre-diabetes

Diagnostic Value of Glycated Haemoglobin (hba1c) Detection As a Screening Test for Diabetes Mellitus

Investigation of the HbA1 C Values in Screening and Diagnosing Type 2 Diabetes Mellitus

Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects

Role of hemoglobin A1c at different cut-off points for diabetes diagnosis

Consistency of fasting blood glucose and OGTT 2h blood glucose for diagnosing prediabetes and diabetes

Clinical Research of Glycated Hemoglobin for Diagnosis of Diabetes Mellitus and Pre-Diabetes

Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects

Comparisons of Validity and Costs of Screening Strategies for Type 2 Diabetes: Population-Based Studies in Shanghai, China

Evaluation on Screening Effects of Diabetes Mellitus and Impaired Glucose Regulation for Two Diabetes Screening Questionnaires

Use of Capillary Glucose Combined with Other Non-Laboratory Examinations to Screen for Diabetes and Prediabetes.

Health Damage and Diabetes Screening Effectiveness Evaluation of Different Fasting Plasma Glucose Cut - Points

Discussion on the HbA1c Screening Its for Diagnostic Cut-Point of Diabetes Mellitus

Combined Assessment of Glycated Albumin and Fasting Plasma Glucose Improves the Detection of Diabetes in Chinese Subjects